We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

World’s First Engineered T Cell Receptor Trial Opens With new Cellular Therapy for HIV

News   Oct 12, 2009

 
World’s First Engineered T Cell Receptor Trial Opens With new Cellular Therapy for HIV
 
 
 

RELATED ARTICLES

Tech Behind Bitcoin Could Improve Medications of the Future

News

Researchers have developed a prototype of an app that may potentially prescribe the optimal dose of medicine for the individual patient, as well as prevent counterfeit products.

READ MORE

Pomegranate Juice During Pregnancy May Improve Brain Development

News

Clinical researchers are exploring whether pomegranate juice intake during pregnancy can have a protective effect. Now, researchers present their preliminary findings from a clinical trial of expectant mothers whose babies were diagnosed with intrauterine growth restriction (IUGR).

READ MORE

Kissing Loops Essential for Tumor Suppression

News

A team of researchers in the Marcia group at EMBL Grenoble have discovered that the tumour suppressor MEG3 adopts a complex three-dimensional structure to fulfil its function. Furthermore, they were able to fine-tune its activity by targeted manipulation of this architecture.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE